Skip to content
Menu

Edwards Lifesciences Corporation EW

Full chart Compare
Set alert

Price alert · EW

All alert types
103.88 USD -1.35 (-1.28%)

Regular-session close

103.88 0.00 0.00%

After hours · Nov 19, 5:15 PM ET

103.49 Day range 105.34
74.66 52-week range 108.00
YTD
+21.85%
1 year
+20.76%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Other Operating Income$59.90MGross Profit$4.74BCost of Revenue$1.33BGross Profit & Other Income$4.80BNet Income$1.07BSelling, General & Admin$2.09BResearch & Development$1.08BOther Expenses$345.80MIncome Tax$216.90MRevenue$6.07BTranscatheter Heart Valves$4.49BSurgical Heart Valve Therapy$1.03BTranscatheter Mitral And Tricuspid Therapies$550.60M

Latest period ending Dec 31, 2025 · select a line to chart its full history

EW annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
6.07B5.44B5.01B4.46B5.23B
4.73B4.32B4.03B3.74B3.98B
1.10B1.38B1.28B1.46B1.57B
1.07B4.17B1.40B1.52B1.50B
1.836.972.302.442.38
EW annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
2.94B3.05B1.13B769.00M862.80M
13.70B13.06B9.36B8.29B8.50B
3.36B2.99B2.64B2.49B2.67B
705.40M700.00M685.10M691.30M690.30M
10.34B10.00B6.65B5.81B5.84B
EW annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.60B542.30M895.80M1.22B1.73B
-712.90M2.31B173.80M252.30M-1.72B
-956.80M-983.00M-711.00M-1.58B-356.30M
-260.20M-252.40M-253.00M-244.60M-325.80M
-119.30M1.91B375.40M-94.80M-332.80M